Get in touch with the right contacts for all of our services.
The Blood and Marrow Transplantation Program of Mayo Clinic, Nemours Children’s Specialty Care, Jacksonville and Wolfson Children’s Hospital has been awarded a three-year accreditation renewal by the Foundation for the Accreditation of Cellular Therapy (FACT). The foundation awarded the accreditation renewal after thorough site visits at all collection, transplantation and laboratory facilities at the three locations.
“We are pleased that Mayo Clinic, Nemours Children’s Clinic and Wolfson Children’s Hospital have met the requirements of the Foundation and have been granted accreditation for their joint Blood and Marrow Transplantation Program,” said Phyllis Warkentin, MD, FACT medical director.
“The teamwork and cooperation between all three organizations in the program has never been better,” said Blood and Marrow Transplant Program Director Michael Joyce, MD, PhD, a pediatric hematologist/oncologist at Nemours Children’s Specialty Care, Jacksonville. “FACT accreditation is a promise to our patients that we are adhering to and meeting the highest standards in the field. The hematology/oncology physicians, nurses, laboratory and support staff of Nemours, Wolfson Children’s and Mayo Clinic work very hard to achieve maintain these standards.”
The joint program was created in 2001 to allow for greater collaboration in physician and staff expertise, research and clinical protocols. Wolfson Children’s Hospital and Nemours Children’s Specialty Care, Jacksonville will celebrate their Blood and Marrow Transplant Program’s 20th anniversary next year. Many patient referrals to the Blood and Marrow Transplant Program come from physicians in Jacksonville, across Florida and south Georgia, across the United States and internationally. Since it was established, the combined program has transplanted patients with a variety of illnesses including leukemia, neuroblastoma, sickle cell disease, bone marrow disorders, multiple myeloma, lymphoma, brain tumors, Ewing’s sarcoma and amyloidosis. Stem cell sources include the patient, immediate family members, volunteer unrelated adult marrow donors or donated umbilical cord blood donor units. More than 970 transplants have been completed during this time.
The program shares a single cryopreservation laboratory (where hematopoietic stem cells are frozen and processed) at Mayo Clinic. Mayo maintains the program’s adult Blood and Marrow Transplant Unit, and Wolfson Children’s Hospital maintains Pediatric Blood and Marrow Transplant beds on the Hematology/Oncology Unit in the J. Wayne and Delores Barr Weaver Tower. The joint program shares information systems, quality and other clinical and administrative staff.
“We are excited to receive this accreditation. It is a welcome recognition and ‘badge of honor’ for our program. It also informs and assures our patients, referring physicians and insurance companies of the highest standards of patient care and laboratory practices in our program,” said Vivek Roy, M.D., hematologist/oncologist at Mayo Clinic in Florida and medical director of the adult Blood and Marrow Transplant Program.
Current medical directors for the program include Michael Joyce, MD, PhD, overall program director and the Pediatric Blood and Marrow Transplant program medical director, Nemours Children’s Clinic and Wolfson Children’s Hospital; Vivek Roy, MD, medical director of the adult Blood and Marrow Transplant Program, Mayo Clinic in Florida; Abba Zubair, MD, PhD, medical director of the adult Apheresis Program and the Cryopreservation Laboratory at Mayo Clinic in Florida; and Jeffrey Goldstein, MD, medical director of the Pediatric Apheresis Program at Wolfson Children’s Hospital.